Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
59,964,750
-
Total 13F shares
-
52,178,300
-
Share change
-
+3,158,116
-
Total reported value
-
$1,197,446,037
-
Put/Call ratio
-
33%
-
Price per share
-
$22.95
-
Number of holders
-
155
-
Value change
-
+$79,392,964
-
Number of buys
-
90
-
Number of sells
-
53
Institutional Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) as of Q3 2018
As of 30 Sep 2018 Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) had 155 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 52,178,300 shares of stock of the company.
Largest 10 holders included BlackRock Inc., Consonance Capital Management LP, Palo Alto Investors LP, Vanguard Group Inc, MACQUARIE GROUP LTD, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, GLENMEDE TRUST CO NA, ADAGE CAPITAL PARTNERS GP, L.L.C., and FMR LLC.
This table shows 155 institutional shareholders of the security as of 30 Sep 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.